trending Market Intelligence /marketintelligence/en/news-insights/trending/erhv3jkbaje78q-o22gxaw2 content esgSubNav
In This List

Entellus Medical shareholders approve Stryker merger

Blog

Commercial Banking: June 22nd Edition

Blog

Understanding Loss Given Default A Review of Three Approaches

Blog

Insight Weekly: Path to net-zero; US manufacturing momentum; China's lithium M&A frenzy

Blog

Commercial Banking Newsletter June Edition - 2022


Entellus Medical shareholders approve Stryker merger

Entellus Medical Inc. shareholders approved the Minnesota-based medical technology company's previously announced merger with Stryker Corp.

Shareholders voted to approve the deal at a special meeting held Feb. 26.

Under the transaction, which was recently cleared by the U.S. Federal Trade Commission, Michigan-based Stryker will pay Entellus shareholders $24 per share.

Entellus Medical makes products for the minimally invasive treatment of patients with chronic and recurrent sinusitis.